The differing kinetics of TGF-β1 production in pathogenic and non-pathogenic immunodeficiency virus infections raise the hypothesis that like type I IFNs, TGF-β1 may play both beneficial and detrimental roles during infection, with early induction contributing to protection whilst sustained upregulation has pathogenic consequences. Here, TGFB1 is linked to infection.